India has approved its first dengue vaccine, Qdenga, for individuals aged 4 to 60, offering a two-dose defence against all ...

An Indian population of the Aedes aegypti mosquito -- the carrier of dengue virus -- may be developing a resistance to ...

Climate change is helping invasive species to not only establish themselves across the continent but to stay alive for longer ...

India's dengue virus is evolving dangerously, with multiple strains circulating, increasing severe illness risks and ...

The Florida Department of Health in Miami-Dade issued an advisory after confirming a case of dengue fever in South ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

The surveillance found that multiple dengue serotypes were circulating across the regions studied, indicating increasing ...

Researchers at the University of Vermont's Robert Larner, M.D. College of Medicine and Upstate Medical University in Syracuse ...

India faces heightened dengue risks as multiple virus strains co-circulate, complicating future vaccination efforts, a new ...

Takeda recently announced that India’s Drug Controller General of India (DCGI) has granted marketing authorization for Takeda’s dengue vaccine (TAK-003) for the prevention of dengue disease in ...

ICMR's first nationwide study found that all four dengue virus strains were circulating in eight Indian states, raising ...

Dengue is a viral infection caused by mosquito bites. Symptoms include fever, severe headache and joint pain. A female Aedes ...